Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Peifer

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Nature Communications|April 18, 2023
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Nature Cell Biology|June 17, 2020
Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levelsTobias Roider, Julian Seufert, Alexey Uvarovskii, et al.
Science Translational Medicine|July 6, 2012
Targeted expression of mutated ALK induces neuroblastoma in transgenic miceLukas C Heukamp, Theresa Thor, Alexander Schramm, et al.
Nature Communications|July 29, 2017
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaGero Knittel, Tim Rehkämper, Darya Korovkina, et al.
Nature Medicine|October 11, 2011
A crucial requirement for Hedgehog signaling in small cell lung cancerKwon-Sik Park, Luciano G Martelotto, Martin Peifer, et al.
Blood|March 28, 2022
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesElena Izquierdo, Daniela Vorholt, Stuart Blakemore, et al.
Cell Stem Cell|December 18, 2018
yylncT Defines a Class of Divergently Transcribed lncRNAs and Safeguards the T-mediated Mesodermal Commitment of Human PSCsStefan Frank, Gaurav Ahuja, Deniz Bartsch, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L Sos, Stefanie Fischer, Roland Ullrich, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Nature Communications|April 18, 2023
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemiaOthman Al-Sawaf, Can Zhang, Hyun Yong Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Nature Cell Biology|June 17, 2020
Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levelsTobias Roider, Julian Seufert, Alexey Uvarovskii, et al.
Science Translational Medicine|July 6, 2012
Targeted expression of mutated ALK induces neuroblastoma in transgenic miceLukas C Heukamp, Theresa Thor, Alexander Schramm, et al.
Nature Communications|July 29, 2017
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaGero Knittel, Tim Rehkämper, Darya Korovkina, et al.
Nature Medicine|October 11, 2011
A crucial requirement for Hedgehog signaling in small cell lung cancerKwon-Sik Park, Luciano G Martelotto, Martin Peifer, et al.
Blood|March 28, 2022
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesElena Izquierdo, Daniela Vorholt, Stuart Blakemore, et al.
Cell Stem Cell|December 18, 2018
yylncT Defines a Class of Divergently Transcribed lncRNAs and Safeguards the T-mediated Mesodermal Commitment of Human PSCsStefan Frank, Gaurav Ahuja, Deniz Bartsch, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L Sos, Stefanie Fischer, Roland Ullrich, et al.
Pageof 11